Mar 212017
 

By Olivier Dellacherie

Talent4Boards - Great Talent builds Great Boards

– USA, CA – SutroVax, a biopharmaceutical company dedicated to the delivery of best-in-class conjugate vaccines and novel complex antigen-based vaccines to prevent serious infectious diseases, today announced the closing of a $60 million Series B financing.… => Read more

SutroVax announces Patrick Heron and Tracy Saxton to its Board along with the closing of $60m Series B financing led by Frazier Healthcare Partners and Pivotal bioVenture Partners

From:: SutroVax announces Patrick Heron and Tracy Saxton to its Board along with the closing of $60m Series B financing led by Frazier Healthcare Partners and Pivotal bioVenture Partners

Sorry, the comment form is closed at this time.

%d bloggers like this: